2009
DOI: 10.1126/science.1174182
|View full text |Cite|
|
Sign up to set email alerts
|

IL-21 Is Required to Control Chronic Viral Infection

Abstract: CD4 + and CD8 + T cell functions are rapidly aborted during chronic infection, preventing viral clearance. CD4 + T cell help is required throughout chronic infection so as to sustain CD8 + T cell responses; however, the necessary factor(s) provided by CD4 + T cells are currently unknown. Using a mouse model of chronic viral infection, we demonstrated that interleukin-21 (IL-21) is an essential component of CD4 + T cell help. In the absence of IL-21 signaling, despite elevated CD4 + T cell responses, CD8 + T ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

27
538
0
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 487 publications
(566 citation statements)
references
References 26 publications
27
538
0
1
Order By: Relevance
“…1, Supplemental Table 1). Although the requirement for CD4 + T cell help throughout chronic infection to sustain CD8 + T cell function (37,38) is not in dispute, PRRactivated DCs could represent a backup mechanism for situations in which CD4 responses are defective. This would be in keeping with findings by other investigators in which the adoptive transfer of autologous DCs loaded in vitro with whole-inactivated HIV-1 or therapeutic vaccination with a recombinant viral vector, both of which recruit functional DCs into the APC pool, induces protective antiviral immunity and viral suppression in the setting of chronic HIV-1 infection (39) and synergizes with PD-L1 neutralization to clear infection in CD4 + T cell help-deficient LCMV clone 13-infected mice (40), respectively.…”
Section: Discussionmentioning
confidence: 99%
“…1, Supplemental Table 1). Although the requirement for CD4 + T cell help throughout chronic infection to sustain CD8 + T cell function (37,38) is not in dispute, PRRactivated DCs could represent a backup mechanism for situations in which CD4 responses are defective. This would be in keeping with findings by other investigators in which the adoptive transfer of autologous DCs loaded in vitro with whole-inactivated HIV-1 or therapeutic vaccination with a recombinant viral vector, both of which recruit functional DCs into the APC pool, induces protective antiviral immunity and viral suppression in the setting of chronic HIV-1 infection (39) and synergizes with PD-L1 neutralization to clear infection in CD4 + T cell help-deficient LCMV clone 13-infected mice (40), respectively.…”
Section: Discussionmentioning
confidence: 99%
“…The common gc cytokines, including IL-7, IL-15, and IL-21, were reported to be above normal levels in chronic HIV-1 infection (19)(20)(21)(22)(23) and, thus, were potential candidates behind Tim-3 induction on T cells. To further understand Tim-3 upregulation in the context of immune responses, PBMCs from healthy donors were stimulated with various cytokines, including members of the common gc family, and Tim-3 expression was analyzed on CD4 + and CD8 + T cells following a 6-d period of stimulation compared with cells cultured in plain medium alone (CD4 + , 5.6 6 2.9%; CD8 + , 6.1 6 5.1%) ( Fig.…”
Section: Lps Does Not Induce Tim-3 Expressionmentioning
confidence: 99%
“…Lastly, we hypothesized that some other soluble inflammatory factor could be behind the Tim-3 expression witnessed during immune activation and tested the common g-chain (gc) cytokines on T cells from individuals not infected with HIV-1. Indeed, IL-7, IL-15, and IL-21 were reported to be elevated in blood plasma during the course of chronic infections (19)(20)(21)(22)(23) and, thus, are likely candidates behind global Tim-3 upregulation.…”
mentioning
confidence: 99%
“…Care was taken to make sure that the patients matched the diagnostic criterias and didn't suffer from chronic diseases such as chronic viral infections (Elsaesser et al, 2009), SLE (Sarra et al, 2010), Rheumatoid Arthritis (Daha et al, 2009), Psoriasis (Liu et al, 2008) and Inflammatory bowel diseases (Liu et al, 2009). Written consent was obtained from all the patients concerned in order to perform this study.…”
Section: Methodsmentioning
confidence: 99%